The TP53 Arg72Pro and MDM2 309G > T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

O.M. Sinilnikova; A.C. Antoniou; J. Simard; S. Healey; M. Leone; D. Sinnett; A.B. Spurdle; J. Beesley; X. Chen; M.H. Greene; J.T. Loud; F. Lejbkowicz; G. Rennert; S. Dishon; I.L. Andrulis; S.M. Domchek; K.L. Nathanson; S. Manoukian; P. Radice; I. Konstantopoulou; I. Blanco; A.L. Laborde; M. Duran; A. Osorio; J. Benitez; U. Hamann; F.B.L. Hogervorst; T.A.M. van Os; J.J.P. Gille; S. Peock; M. Cook; C. Luccarini; D.G. Evans; F. Lalloo; R. Eeles; G. Pichert; R. Davidson; T. Cole; J. Cook; J. Paterson; C. Brewer; D.J. Hughes; I. Coupier; S. Giraud; F. Coulet; C. Colas; F. Soubrier; E. Rouleau; I. Bieche; R. Lidereau; L. Demange; C. Nogues; H.T. Lynch; R.K. Schmutzler; B. Versmold; C. Engel; A. Meindl; N. Arnold; C. Sutter; H. Deissler; D. Schaefer; U.G. Froster; K. Aittomaki; H. Nevanlinna; L. McGuffog; D.F. Easton; G. Chenevix-Trench; D. Stoppa-Lyonnet

doi:https://doi.org/10.1038/sj.bjc.6605279

The TP53 Arg72Pro and MDM2 309G > T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

O.M. Sinilnikova, A.C. Antoniou, J. Simard, S. Healey, M. Leone, D. Sinnett, A.B. Spurdle, J. Beesley, X. Chen, M.H. Greene, J.T. Loud, F. Lejbkowicz, G. Rennert, S. Dishon, I.L. Andrulis, S.M. Domchek, K.L. Nathanson, S. Manoukian, P. Radice, I. KonstantopoulouI. Blanco, A.L. Laborde, M. Duran, A. Osorio, J. Benitez, U. Hamann, F.B.L. Hogervorst, T.A.M. van Os, J.J.P. Gille, S. Peock, M. Cook, C. Luccarini, D.G. Evans, F. Lalloo, R. Eeles, G. Pichert, R. Davidson, T. Cole, J. Cook, J. Paterson, C. Brewer, D.J. Hughes, I. Coupier, S. Giraud, F. Coulet, C. Colas, F. Soubrier, E. Rouleau, I. Bieche, R. Lidereau, L. Demange, C. Nogues, H.T. Lynch, R.K. Schmutzler, B. Versmold, C. Engel, A. Meindl, N. Arnold, C. Sutter, H. Deissler, D. Schaefer, U.G. Froster, K. Aittomaki, H. Nevanlinna, L. McGuffog, D.F. Easton, G. Chenevix-Trench, D. Stoppa-Lyonnet

Human Genetics (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

19 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1456-1460
Journal	British journal of cancer
Volume	101
Issue number	8
DOIs	https://doi.org/10.1038/sj.bjc.6605279
Publication status	Published - 2009

Access to Document

https://doi.org/10.1038/sj.bjc.6605279

https://research.vumc.nl/ws/files/776410/262175.pdf

Cite this

Sinilnikova, O. M., Antoniou, A. C., Simard, J., Healey, S., Leone, M., Sinnett, D., Spurdle, A. B., Beesley, J., Chen, X., Greene, M. H., Loud, J. T., Lejbkowicz, F., Rennert, G., Dishon, S., Andrulis, I. L., Domchek, S. M., Nathanson, K. L., Manoukian, S., Radice, P., ... Stoppa-Lyonnet, D. (2009). The TP53 Arg72Pro and MDM2 309G > T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. British journal of cancer, 101(8), 1456-1460. https://doi.org/10.1038/sj.bjc.6605279

@article{dbf729a007e243718c3c74b0505acd1b,

title = "The TP53 Arg72Pro and MDM2 309G > T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers",

author = "O.M. Sinilnikova and A.C. Antoniou and J. Simard and S. Healey and M. Leone and D. Sinnett and A.B. Spurdle and J. Beesley and X. Chen and M.H. Greene and J.T. Loud and F. Lejbkowicz and G. Rennert and S. Dishon and I.L. Andrulis and S.M. Domchek and K.L. Nathanson and S. Manoukian and P. Radice and I. Konstantopoulou and I. Blanco and A.L. Laborde and M. Duran and A. Osorio and J. Benitez and U. Hamann and F.B.L. Hogervorst and {van Os}, T.A.M. and J.J.P. Gille and S. Peock and M. Cook and C. Luccarini and D.G. Evans and F. Lalloo and R. Eeles and G. Pichert and R. Davidson and T. Cole and J. Cook and J. Paterson and C. Brewer and D.J. Hughes and I. Coupier and S. Giraud and F. Coulet and C. Colas and F. Soubrier and E. Rouleau and I. Bieche and R. Lidereau and L. Demange and C. Nogues and H.T. Lynch and R.K. Schmutzler and B. Versmold and C. Engel and A. Meindl and N. Arnold and C. Sutter and H. Deissler and D. Schaefer and U.G. Froster and K. Aittomaki and H. Nevanlinna and L. McGuffog and D.F. Easton and G. Chenevix-Trench and D. Stoppa-Lyonnet",

year = "2009",

doi = "https://doi.org/10.1038/sj.bjc.6605279",

language = "Undefined/Unknown",

volume = "101",

pages = "1456--1460",

journal = "The British journal of cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "8",

}

Sinilnikova, OM, Antoniou, AC, Simard, J, Healey, S, Leone, M, Sinnett, D, Spurdle, AB, Beesley, J, Chen, X, Greene, MH, Loud, JT, Lejbkowicz, F, Rennert, G, Dishon, S, Andrulis, IL, Domchek, SM, Nathanson, KL, Manoukian, S, Radice, P, Konstantopoulou, I, Blanco, I, Laborde, AL, Duran, M, Osorio, A, Benitez, J, Hamann, U, Hogervorst, FBL, van Os, TAM, Gille, JJP, Peock, S, Cook, M, Luccarini, C, Evans, DG, Lalloo, F, Eeles, R, Pichert, G, Davidson, R, Cole, T, Cook, J, Paterson, J, Brewer, C, Hughes, DJ, Coupier, I, Giraud, S, Coulet, F, Colas, C, Soubrier, F, Rouleau, E, Bieche, I, Lidereau, R, Demange, L, Nogues, C, Lynch, HT, Schmutzler, RK, Versmold, B, Engel, C, Meindl, A, Arnold, N, Sutter, C, Deissler, H, Schaefer, D, Froster, UG, Aittomaki, K, Nevanlinna, H, McGuffog, L, Easton, DF, Chenevix-Trench, G & Stoppa-Lyonnet, D 2009, 'The TP53 Arg72Pro and MDM2 309G > T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers', British journal of cancer, vol. 101, no. 8, pp. 1456-1460. https://doi.org/10.1038/sj.bjc.6605279

TY - JOUR

T1 - The TP53 Arg72Pro and MDM2 309G > T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

AU - Sinilnikova, O.M.

AU - Antoniou, A.C.

AU - Simard, J.

AU - Healey, S.

AU - Leone, M.

AU - Sinnett, D.

AU - Spurdle, A.B.

AU - Beesley, J.

AU - Chen, X.

AU - Greene, M.H.

AU - Loud, J.T.

AU - Lejbkowicz, F.

AU - Rennert, G.

AU - Dishon, S.

AU - Andrulis, I.L.

AU - Domchek, S.M.

AU - Nathanson, K.L.

AU - Manoukian, S.

AU - Radice, P.

AU - Konstantopoulou, I.

AU - Blanco, I.

AU - Laborde, A.L.

AU - Duran, M.

AU - Osorio, A.

AU - Benitez, J.

AU - Hamann, U.

AU - Hogervorst, F.B.L.

AU - van Os, T.A.M.

AU - Gille, J.J.P.

AU - Peock, S.

AU - Cook, M.

AU - Luccarini, C.

AU - Evans, D.G.

AU - Lalloo, F.

AU - Eeles, R.

AU - Pichert, G.

AU - Davidson, R.

AU - Cole, T.

AU - Cook, J.

AU - Paterson, J.

AU - Brewer, C.

AU - Hughes, D.J.

AU - Coupier, I.

AU - Giraud, S.

AU - Coulet, F.

AU - Colas, C.

AU - Soubrier, F.

AU - Rouleau, E.

AU - Bieche, I.

AU - Lidereau, R.

AU - Demange, L.

AU - Nogues, C.

AU - Lynch, H.T.

AU - Schmutzler, R.K.

AU - Versmold, B.

AU - Engel, C.

AU - Meindl, A.

AU - Arnold, N.

AU - Sutter, C.

AU - Deissler, H.

AU - Schaefer, D.

AU - Froster, U.G.

AU - Aittomaki, K.

AU - Nevanlinna, H.

AU - McGuffog, L.

AU - Easton, D.F.

AU - Chenevix-Trench, G.

AU - Stoppa-Lyonnet, D.

PY - 2009

Y1 - 2009

U2 - https://doi.org/10.1038/sj.bjc.6605279

DO - https://doi.org/10.1038/sj.bjc.6605279

M3 - Article

C2 - 19707196

SN - 0007-0920

VL - 101

SP - 1456

EP - 1460

JO - The British journal of cancer

JF - The British journal of cancer

IS - 8

ER -